Thomas Dayspring (@drlipid) 's Twitter Profile
Thomas Dayspring

@drlipid

MD, FACP, FNLA - Clinical Lipidologist: Tweets/Re-Tweets do not represent endorsements/medical advice

ID: 56916619

calendar_today15-07-2009 03:50:32

19,19K Tweet

37,37K Followers

602 Following

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

Impactful study - Perhaps (HOPEFULLY) the final nail in the coffin as to why it is absurd to use the term GOOD CHOLESTROL - any clinician using that archaic term should lose their license

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

Nice to have my declaration re docs misleading folks about high HDL-C or even worse the TC/HDL-C ratio to be sustained by a top cardiologist/lipidologist.

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

With respect to the authors, like so many guidelines these will have little use in the real world and will be ignored. I agree with Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 on the misclassification of risk categories. Likewise it is also absurd to still suggest using high dose statins which almost no clinicians

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

Lipidaholics: Continuing the tutorial on cholesterol homeostasis by looking at the individual steps of hepatocellular cholesterol homeostasis. As always, the issues are way more complicated than I depict here. Many will be surprised that cholesterol can move from the bile back

Lipidaholics: Continuing the tutorial on cholesterol homeostasis by looking at the individual steps of hepatocellular cholesterol homeostasis.  As always, the issues are way more complicated than I depict here. Many will be surprised that cholesterol can move from the bile back
Thomas Dayspring (@drlipid) 's Twitter Profile Photo

This is an incredible open access Primary Prevention advice - Just about the best I have seen. ApoB oriented, no specific TG goal - although they should be tested or for sure no HDL-C goal. None of the absolute high-intensity statin silliness for primary prevention

This is an incredible open access Primary Prevention advice - Just about the best I have seen. ApoB oriented, no specific TG goal - although they should be tested or for sure no HDL-C goal. None of the absolute high-intensity statin silliness for primary prevention
European Atherosclerosis Society (@society_eas) 's Twitter Profile Photo

The call for Anitschkow Prize 2025 nominations is now open! This esteemed prize, presented annually by the EAS, honors outstanding researchers who have made significant contributions to the field of atherosclerosis and related metabolic disturbances. eas.to/Anitschkow2025…

The call for Anitschkow Prize 2025 nominations is now open! This esteemed prize, presented annually by the EAS, honors outstanding researchers who have made significant contributions to the field of atherosclerosis and related metabolic disturbances. eas.to/Anitschkow2025…
Thomas Dayspring (@drlipid) 's Twitter Profile Photo

Lipidaholics - Continuing with my tutorial on the individual steps of hepatocellular cholesterol homeostasis. As always, the issues are way more complicated than I depict here. The LDLR regulates apoB (and apoE) particle clearance - Decreased clearance of LDLs is #1 cause of

Lipidaholics - Continuing with my tutorial on the individual steps of hepatocellular cholesterol homeostasis. As always, the issues are way more complicated than I depict here. The LDLR regulates apoB (and apoE) particle clearance - Decreased clearance of LDLs is #1 cause of
National Lipid Association (@nationallipid) 's Twitter Profile Photo

Today's #LipidXcellence comes to us from the Foundation of the NLA with their #TweetorialTuesday breaking down what your patients need to know about lipid testing and what resources are available to them! Share with your patients! #CholesterolMonth #LipidXcellence #KnowledgeIsPower

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

I think some are misusing my response tweet below. Yes cholesterol is needed by all cells (to a very small degree) but equally true is the fact that excess cellular cholesterol can be incredibly toxic as it crystallizes and kills cells (lipotoxic). Importantly tissue (cellular)

Thomas Dayspring (@drlipid) 's Twitter Profile Photo

Lipidaholics - Continuing with the next step in my tutorial on the individual steps of hepatocellular cholesterol homeostasis. As always, the issues are way more complicated than I depict here. SR-B1 is a fascinating bidirectional membrane transporter that can both lipidate or

Lipidaholics - Continuing with the next step in my tutorial on the individual steps of hepatocellular cholesterol homeostasis. As always, the issues are way more complicated than I depict here. SR-B1 is a fascinating bidirectional membrane transporter that can both lipidate or
Thomas Dayspring (@drlipid) 's Twitter Profile Photo

More solid trial data to further bury the cholesterol denialists. Hope they read the manuscript. The great CARDIA study - Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood - THE LDLc & NON-HDL-C LEVELS IN YOUNG THAT BEST PREDICT RISK ARE FAR

More solid trial data to further bury the cholesterol denialists. Hope they read the manuscript.   The great CARDIA study - Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood   -  THE LDLc & NON-HDL-C LEVELS IN YOUNG THAT BEST PREDICT RISK ARE FAR
Thomas Dayspring (@drlipid) 's Twitter Profile Photo

Sorry deniers - Here is the editorial (CAPS are mine) that refutes everything you believe - "We need to be identifying more effective strategies [HOW ABOUT APOB] for lipid screening and lowering in this segment of the population [YOUNG ADULTS], and reducing health inequity by

Sorry deniers - Here is the editorial (CAPS are mine) that refutes everything you believe - "We need to be identifying more effective strategies [HOW ABOUT APOB] for lipid screening and lowering in this segment of the population [YOUNG ADULTS], and reducing health inequity by
European Atherosclerosis Society (@society_eas) 's Twitter Profile Photo

The final hours of waiting for our third LatAm webinar! Today at 18:00 CET, we will explore more about triglyceride-rich lipoproteins as contributors to residual risk. You still have a chance to join us. Register here: eas.to/LatAmWeb3Reg

The final hours of waiting for our third LatAm webinar! Today at 18:00 CET, we will explore more about triglyceride-rich lipoproteins as contributors to residual risk. You still have a chance to join us. Register here: eas.to/LatAmWeb3Reg
Thomas Dayspring (@drlipid) 's Twitter Profile Photo

This will surprise most: LDL receptors which clear the apoB-cholesterol carrying lipoproteins from plasma can be upregulated and act very quickly. When hepatic (liver) pools of cholesterol are depleted by any intervention like diet or drugs, plasma cholesterol levels change